Thiourea → HCID 178451223、化合物
反応式
Cl[C:2]1[N:6]([CH2:7][C:8]([O:10][C:11]([CH3:14])([CH3:13])[CH3:12])=[O:9])[C:5]2[CH:15]=[CH:16][CH:17]=[CH:18][C:4]=2[N:3]=1.NC(N)=[S:21]>CO>[C:11]([O:10][C:8](=[O:9])[CH2:7][N:6]1[C:5]2[CH:15]=[CH:16][CH:17]=[CH:18][C:4]=2[N:3]=[C:2]1[SH:21])([CH3:14])([CH3:13])[CH3:12]参加物
実験手順
According to the procedure described in: Migawa, M. T.; Girardet, J.-L.; Walker II, J. A.; Koszalka, G. W.; Chamberlain, S. D.; Drach, J. C.; Townsend, L. B., J. Med. Chem. 1998, 41, 1242-1251, a solution of tert-butyl (2-chloro-benzoimidazol-1-yl)-acetate (Intermediate 2-I, 7 g, 26.3 mmol) and thiourea (7.98 g, 105 mmol) in methanol (100 ml) is refluxed for 2 h. The mixture is cooled down and most of the methanol is removed in vacuo. After addition of saturated aqueous NH4Cl solution (150 ml), the resulting aqueous phase is extracted three times with Et2O. The combined organic phases are washed with brine and dried over Na2SO4. The solvent is evaporated in vacuo and the residue dried under high vacuum, yielding the title compound (6.46 g) in 93% as a white powder: tR=6.14 min (LC-1), ESI-MS (neg.): m/z 263.31 [M−H]+; 1H-NMR (CDCl3): δ (ppm) 1.50 (s, 9H, tBu), 4.94 (s, 2H, CH2CO2), 6.99-7.05 (m, 1 Harom), 7.16-7.24 (m, 1Harom), 10.69 (bs, 1H, SH).
後処理
- customis removed in vacuo
- additionAfter addition of saturated aqueous NH4Cl solution (150 ml)
- extractionthe resulting aqueous phase is extracted three times with Et2O
- washThe combined organic phases are washed with brine
- dry with materialdried over Na2SO4
- customThe solvent is evaporated in vacuo
- customthe residue dried under high vacuum
出典と根拠
- ORDレコード
- ord-aacda600cbb84607942fb46c6aa58064
- 出典データセット
- uspto-grants-2012_09
- 特許番号
- US08273740B2
反応ノート
読み込み中…